drugset / Trial / NCT03211455

Intravenous Lidocaine in Bariatric Surgery.

NCT03211455 ↗

Phase 3 Completed 180 enrolled University Hospital, Caen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Although peroperative intravenous lidocaine has been shown to be useful in early recovery after colorectal surgery, its beneficial effect on the specific population of obese patients scheduled for bariatric surgery remained unknown. Investigators hypothesized that peroperative intravenous lidocaine could decrease postoperative opioid consumption and improve postoperative recovery

Timeline

Start
2017-12-01
Primary completion
2019-02-01
Completion
2019-05-01

Outcome

Met primary endpoint

paper difference between medians (95%CI): 1.7 (0.6-3.4) mg; p = 0.004). PMID 32564365 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications